Amplifi Vascular, Inc.
Last verified 2026-05-06. JSON
| Total raised | $5.9M |
|---|---|
| Latest round | Funding round, $5.9M, 2024-08-21 |
| Founded | 2023 |
| Headquarters | Prairie Village, KS |
| Industry | biotech |
| Stage | unknown |
| Website | amplifivascular.com |
Amplifi Vascular develops the Amplifi Vein Dilation System, a wearable external blood pump that enlarges arm veins before arteriovenous fistula surgery for hemodialysis access. It serves hemodialysis patients with small veins otherwise ineligible for fistula creation. Preoperative vein conditioning addresses fistula maturation failure that drug and surgical-technique alternatives do not solve.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-08-21 | Funding round | $5.9M | undisclosed |
Detected tech stack
Cloudflare, reCAPTCHA, Google Analytics, Google Tag Manager, jQuery Migrate, parallax.js, PHP, DoubleClick Floodlight, WordPress, WordPress Block Editor, MySQL, jquery 3.7.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $5.9M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $5.9M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | amplifivascular.com, read 2026-05-06 |
| Description | self-reported | amplifivascular.com, read 2026-05-06 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $5.9M, 2024-08-21 → Funding round, $5.9M, 2024-08-21, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $5.9M, 2024-08-21 → Funding round, $5.9M, 2024-08-21 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes